Click Here to return To Results

 

IM Interferon B-1a Delays Definite Multiple Sclerosis 5 Years After a First Demyelinating Event Neurol 66:678-684, CHAMPIONS Study Group, 2006 See this aricle in Pubmed Article Abstract These results support the use of IM interferon B-1a after a first clinical demyelinating event and indicate that there may be modest beneficial effects of immediate treatment compared with delayed initiation of treatment.

Related Tags

(click to filter results - removes previous filter) interferon interferon beta 1-a multiple sclerosis multiple sclerosis,monosymptomatic multiple sclerosis,treatment of multiple sclerosis,treatment of,first attack treatment of neurologic disorder

Click Here to return To Results